SCHEMBL19953750

SCHEMBL19953750

COC(Cc1ccc(S(C)(=O)=O)cc1)(C(=O)O)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.42
EPHX2 P34913 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
ENPP2 Q13822 1/20 0.40
PTPRB P23467 4/20 0.40
AKR1C3 P42330 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPRA P18433 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
PTGS2 P35354 2/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK8 P45983 1/20 0.37
ITGB1 P05556 1/20 0.37
ITGA4 P13612 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20333774 0.86 PTPN1 (0.41) PTPN1EPHX2NR1H4ENPP2PTPRB
SCHEMBL20350669 0.84 EPHX2 (0.42) PTPN1EPHX2NR1H4ENPP2AKR1C3
SCHEMBL934104 0.79 SMN1; SMN2 (0.52) PTPN1PTPRBPTPN2PTPRA
SCHEMBL20333381 0.78 RXRA (0.39) PTPN1PTPRBPTPN2PTPRA
SCHEMBL20350718 0.78 ALDH1A1 (0.50) PTPRBMEN1KMT2A
SCHEMBL27769567 0.77 EPHX2 (0.46) PTPN1EPHX2NR1H4ENPP2AKR1C3
SCHEMBL20333769 0.75 FFAR1 (0.50)
SCHEMBL29975802 0.75 BLM (0.44) PTPN1EPHX2NR1H4ENPP2AKR1C3
SCHEMBL20333384 0.73 SMN1; SMN2 (0.50) PTPN1NR1H4MEN1KMT2A
SCHEMBL15577125 0.72 BLM (0.40) PTPN1EPHX2PTPRBPTPN2PTPRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510040-A1 ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF Calithera Biosciences, Inc. (US) 2019-07-17 EP disclosed
WO-2018049145-A1 ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF CALITHERA BIOSCIENCES, INC. (US) 2018-03-15 WO disclosed